Article Text

PDF
SAT0485 Patiens with Early-Onset Juvenile Spondyloarthropaties: A Distinct Population
  1. M.M. Katsicas,
  2. R.A. Russo
  1. Service of Immunology & Rheumatology, Hospital de Pediatrìa Prof Dr J P. Garrahan, Buenos Aires, Argentina

Abstract

Background The Juvenile spondyloarthropaties (JSpA) are a group of related, clinically heterogeneous, seronegative rheumatic diseases. Usually disease onset occurs in late childhood (after 8 years)1 or adolescence. However, younger patients have been reported, making its diagnosis difficult at an early age. There is sparse information about the clinical features of JSpA in patients with disease onset before 8 years.

Objectives To describe and analyze disease features at onset and during the disease course in patients with JSpA starting before 8 years. To compare such characteristics with patients with disease onset after 8 years.

Methods Retrospective analysis of clinical data obtained from patients with JSpA (defined as ERA, JPsA or UA according to ILAR) followed in a tertiary center. Patiens were divided into 2 groups: disease onset ≤8 yo and disease onset >8 yo. Recorded variables included: age at onset, sex, disease duration before first visit; clinical features at disease onset and during disease course: number of active joints, number of limited joints, articular pattern (symmetric-asymmetric, oigoarticular/polyarticular, small/large joints and upper/lower limbs), axial involvement (limitation of lumbar spine motion, low back pain), presence of enthesitis, tarsitis, dactylitis, uveitis, radiologic sacroiliitis, diarrhea, urethritis, psoriasis, inflammatory bowel disease, fever, positive HLAB-27 and family history, lowest hemoglobin level, highest erythrocyte sedimentation rate (ESR). Outcome measures (at last visit): activity (BASDAI) and functional capacity (BASFI and CHAQ), use of biologics and presence of bone damage. Chi square and Mann-Whitney tests were used for comparisons

Results 110 patiens with JSpA followed for median 7 years were included (M: 96, 87%). Disease onset ≤8 y.o ocurred in 20 (18%) children. Age at onset was 6 (1-8) y in the early onset group and 11 (9-16)y in the later onset group. Diagnosis delay (8 vs 6 months) was similar. Patients with disease onset ≤8 y differed from patients with disease onset >8 y in: articular pattern (symmetric 45% vs 22%, p=0.04) and polyarticular (40% vs 14%, p=0.0097), dactylitis (25% vs 8%, p=0.024), uveitis (25% vs 3%, p=0.0048), positive HLA B-27 (60% vs 20%, p=0.0007), lowest hemoglobin (11 g/dl vs 12.5 g/dl, p=0.0004), ESR (55 mm/h vs 28.5 mm/h, p=0.047) at onset. During disease course patients showed differences in: sacroiilitis (50% vs 22%, p=0.0003), persistent dactylitis (25% vs 7%, p=0.0049), radiographic bone damage (25% vs 7%, p=0.03) and use of biologics (55% vs 21%, p=0.0036). No differences in activity and functional capacity outcomes were found between both groups.

Conclusions JSpA patients with disease onset before 8 yo show more inflammatory features at disease onset. These findings seem to identify a distinct population. Recognizing these findings at onset would allow a correct classification of younger patients with JSpA.

References

  1. Petty RE, Southwood TR, Baum J; Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orosco-Alcala J, Prier AM. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998 Oct;25(10):1991-4.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.